A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients with Spinal Muscular Atrophy (SMA)

Project: Research project

Project Details

StatusActive
Effective start/end date9/22/168/31/50

Funding

  • Cytokinetics, Inc.